Related Experiment Videos
[Production and characterization of a new prothrombin complex concentrate]
Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1985
Summary
A simplified DEAE-sephadex A 50 adsorption method efficiently produces prothrombin complex concentrates from human plasma. This technique enhances manufacturing efficiency for critical blood products.
Area of Science:
- Biochemistry
- Hematology
- Biotechnology
Context:
- Prothrombin complex concentrates (PCC) are vital for treating coagulation factor deficiencies.
- Current manufacturing methods can be complex and costly.
- Optimizing PCC production is crucial for clinical accessibility.
Purpose:
- To describe a simplified procedure for producing prothrombin complex concentrates.
- To detail the technical appliances used in the adsorption process.
- To demonstrate improved manufacturing efficiency using DEAE-sephadex A 50.
Summary:
- A novel procedure utilizes DEAE-sephadex A 50 adsorption for prothrombin complex concentrate production from human citrate plasma.
- The method simplifies existing techniques, enabling efficient large-scale manufacturing (10 L batches).
- Technical aspects and developed appliances for this process are elaborated.
Impact:
- This simplified technique enhances the efficient manufacture of prothrombin complex concentrates.
- Potential for reduced production costs and increased availability of essential hemostatic agents.
- Contributes to advancements in blood product manufacturing and hematological therapies.